COMPARING COST-UTILITY OF DMARDs IN AUTOANTIBODY-NEGATIVE RHEUMATOID ARTHRITIS PATIENTS.
Sign Up to like & getrecommendations! Published in 2021 at "Rheumatology"
DOI: 10.1093/rheumatology/keab251
Abstract: OBJECTIVES To evaluate the 1-year cost-effectiveness between three different initial treatment strategies in autoantibody-negative rheumatoid arthritis(RA-) patients, according to 2010 criteria. MATERIALS AND METHODS For this analysis we selected all RA- patients within the intermediate… read more here.
Keywords: negative rheumatoid; ihcq; arthritis patients; autoantibody negative ... See more keywords
Enhanced treatment strategies and distinct disease outcomes among autoantibody-positive and -negative rheumatoid arthritis patients over 25 years: A longitudinal cohort study in the Netherlands
Sign Up to like & getrecommendations! Published in 2020 at "PLoS Medicine"
DOI: 10.1371/journal.pmed.1003296
Abstract: Background Based on different genetic and environmental risk factors and histology, it has been proposed that rheumatoid arthritis (RA) consists of 2 types: autoantibody-positive and autoantibody-negative RA. However, until now, this remained hypothetical. To assess… read more here.
Keywords: autoantibody; treatment; autoantibody positive; autoantibody negative ... See more keywords